TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Orion Pharma AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
928,999
|
787,123
|
788,348 |
| Financial expenses |
9
|
2
|
15 |
| Earnings before taxes |
40,217
|
33,147
|
21,993 |
| EBITDA |
38,586
|
32,804
|
22,305 |
| Total assets |
217,721
|
267,018
|
230,890 |
| Current assets |
214,347
|
263,653
|
227,269 |
| Current liabilities |
40,829
|
116,735
|
90,755 |
| Equity capital |
173,761
|
147,430
|
137,304 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
49
|
48
|
48 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
79.8%
|
55.2%
|
59.5% |
| Turnover per employee |
18,959
|
16,398
|
16,424 |
| Profit as a percentage of turnover |
4.3%
|
4.2%
|
2.8% |
| Return on assets (ROA) |
18.5%
|
12.4%
|
9.5% |
| Current ratio |
525.0%
|
225.9%
|
250.4% |
| Return on equity (ROE) |
23.1%
|
22.5%
|
16.0% |
| Change turnover |
86,024
|
22,468
|
-365 |
| Change turnover % |
10%
|
3%
|
0% |
| Chg. No. of employees |
1
|
0
|
-5 |
| Chg. No. of employees % |
2%
|
0%
|
-9% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.